Author: Gary Wilhelm
-
Startup Spotlight: UNC-linked startup is giving hope to those with hemophilia
GeneVentiv Therapeutics is developing the first universal gene therapy for all types of hemophilia, including the most difficult cases. By working to bring breakthrough therapies to market, this UNC-affiliated startup is also instilling expanded hope in hemophilia patients who wrestle with the daily realities of their life threatening, inherited disorder.
-
UNC’s vice chancellor for innovation, entrepreneurship is retiring
After 11 years of dedicated service and commitment to the University and the state, Judith Cone, vice chancellor for innovation, entrepreneurship and economic development, will retire from Carolina in April.
-
Durham-based 410 Medical wins Entrepreneurial Company of Year award
Frost & Sullivan, a California company specializing in business growth and development, has named Durham’s 410 Medical, Inc. as the 2021 Entrepreneurial Company of the Year in the global fluid resuscitation devices industry.
-
Target RWE Acquires NoviSci, Gains Amgen Investment
Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess. The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away.
-
Biotech giant Amgen is doubling down on a Durham health data startup with ties to Duke
Amgen, one of the largest biotechnology companies in the world, is doubling down on its investment into a Durham health data startup called NoviSci. NoviSci, founded by two Duke University professors, builds statistical software that companies use to evaluate the effectiveness of drugs in patients.
-
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop, and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC-based developer of RNA-based small molecule therapeutics.
-
410 Medical Awarded FDA 510k Clearance for LifeFlow PLUS
Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).
-
National Academy of Engineering Recognizes Ligler With Leadership Award
Frances S. Ligler, Ross Lampe Distinguished Professor in the UNC/NC State Joint Department of Biomedical Engineering, has been recognized by the National Academy of Engineering (NAE) with its Simon Ramo Founders Award.
-
BME Spin-out Company Altis Biosystems announces completion of a $3.1 million investment
Altis Biosystems, a company co-founded by BME Associate Professor Scott Magness and former chair Dr. Nancy Allbritton, recently announced completion of a $3.1 million seed investment led by VentureSouth.
-
Carrboro biotech startup Inhalon Biopharma adds $912K to its coffers
Inhalon Biopharma, a biotech startup founded by UNC-Chapel Hill researchers, is getting closer to reaching its $3.2 million fundraising goal.